Literature DB >> 9876824

Hepatic injury associated with losartan.

R J Andrade, M I Lucena, F Santalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9876824     DOI： 10.1345/aph.18087a

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Drug points: prolonged cholestasis associated with irbesartan.

Authors:  R Hariraj; E Stoner; S Jader; D M Preston
Journal:  BMJ       Date:  2000-09-02

2.  Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review.

Authors:  Moh'd Z Al-Halawani; Mohammad Thawabi; Fady Asslo; Hamid Shaaban; Fayez Shamoon; Walid J Baddoura
Journal:  J Family Med Prim Care       Date:  2014-07

3.  Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis.

Authors:  Golnar Karimian; Manon Buist-Homan; Bojana Mikus; Robert H Henning; Klaas Nico Faber; Han Moshage
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

4.  Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.

Authors:  Dae Hwa Park; Gee Young Yun; Hyuk Soo Eun; Jong Seok Joo; Ju Seok Kim; Sun Hyung Kang; Hee Seok Moon; Eaum Seok Lee; Byung Seok Lee; Kyung Hee Kim; Seok Hyun Kim
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.